<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Module 15: Lesson 1 - The Estrobolome: The Gut-Hormone Axis</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - TEAL theme for Advanced Hormonal Interplay */
        .module-header {
            background: linear-gradient(135deg, #0d9488 0%, #14b8a6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0d9488;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0d9488;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdfa;
            border: 2px solid #14b8a6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #14b8a6;
        }

        .term-item .term {
            font-weight: 700;
            color: #0d9488;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0d9488;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #0d9488;
            font-weight: 700;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.info {
            background: #e0f2f1;
            border-left-color: #00897b;
        }

        .alert-box.info .alert-label {
            color: #00695c;
        }

        /* Data Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background-color: #f9fafb;
            color: #374151;
            font-weight: 600;
            padding: 12px 15px;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 12px 15px;
            border-bottom: 1px solid #f3f4f6;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0d9488 0%, #14b8a6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #14b8a6, #0d9488);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #0d9488;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #065f46;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f0fdf4;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Key Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .takeaways-box .box-label {
            font-weight: 600;
            color: #0d9488;
            margin: 0 0 15px 0;
            font-size: 16px;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* References Box */
        .references-box {
            margin-top: 50px;
            padding: 30px;
            background: #f9fafb;
            border-radius: 12px;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            font-size: 16px;
            color: #374151;
        }

        .references-box ul {
            margin: 0;
            padding-left: 18px;
            list-style-type: decimal;
        }

        .references-box li {
            font-size: 13px;
            color: #6b7280;
            margin-bottom: 8px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
            opacity: 0.9;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 15: Advanced Hormonal Interplay</p>
            <h1 class="lesson-title">Lesson 1: The Estrobolome: The Gut-Hormone Axis</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Defining the Estrobolome</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The Conjugation Loop</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Beta-Glucuronidase: The Gatekeeper</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Dysbiosis & Estrogen Dominance</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Interventions & Nutraceuticals</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Advanced Case Study</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the biochemical mechanisms of the <span class="highlight">estrobolome</span> and its influence on systemic estrogen.</li>
                <li>Analyze the role of <span class="highlight">beta-glucuronidase</span> in the enterohepatic circulation of hormones.</li>
                <li>Integrate gut health assessment into the <span class="highlight">Baseline Assessment (B)</span> of The B.L.O.O.M. Methodâ„¢.</li>
                <li>Develop targeted nutritional protocols using fiber, cruciferous compounds, and Calcium-D-Glucarate.</li>
                <li>Evaluate clinical presentations of gut-driven estrogen dominance through case study analysis.</li>
            </ul>
        </div>

        <h2 id="section1">1. Defining the Estrobolome: The Functional Niche</h2>
        <p>In previous modules, we explored the liver's role in phase 1 and phase 2 detoxification. However, the journey of an estrogen molecule does not end when it leaves the liver. The <span class="highlight">estrobolome</span>, a term coined by Plottel and Blaser in 2011, refers to the aggregate of enteric bacterial genes whose products are capable of metabolizing estrogens.</p>
        
        <p>This "functional niche" within the gut microbiome acts as a secondary endocrine organ. It determines whether estrogens are excreted in the feces or deconjugated and <span class="highlight">reabsorbed</span> back into the bloodstream. A healthy estrobolome maintains homeostasis; an impaired one creates a feedback loop that drives hormonal pathology.</p>

        <div class="alert-box info">
            <p class="alert-label">The B.L.O.O.M. Methodâ„¢ Insight</p>
            <p>Within our framework, the estrobolome represents the critical intersection between <strong>Baseline Assessment (B)</strong> and <strong>Optimize Hormones (O)</strong>. You cannot optimize estrogen if the baseline gut environment is recycling waste back into circulation.</p>
        </div>

        <h2 id="section2">2. The Conjugation-Deconjugation Loop</h2>
        <p>To understand the estrobolome, we must track the "life cycle" of an estrogen molecule. After circulating and performing its physiological duties, estrogen is sent to the liver. Here, it undergoes <span class="highlight">glucuronidation</span>â€”a process where a glucuronic acid molecule is attached to the estrogen, making it water-soluble and "packaged" for exit via bile into the intestines.</p>

        <p>Under ideal conditions, this "packaged" estrogen travels through the digestive tract and is excreted. However, certain bacteria in the gut produce an enzyme called <span class="highlight">beta-glucuronidase</span>. This enzyme acts like a pair of chemical scissors, snipping the glucuronic acid bond. Once "unzipped," the estrogen becomes fat-soluble again, allowing it to cross the gut lining and re-enter the <span class="highlight">enterohepatic circulation</span>.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Process Phase</th>
                        <th>Location</th>
                        <th>Hormonal State</th>
                        <th>Outcome</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Phase 2 Detox</td>
                        <td>Liver</td>
                        <td>Conjugated (Inactive)</td>
                        <td>Prepared for excretion</td>
                    </tr>
                    <tr>
                        <td>Healthy Estrobolome</td>
                        <td>Lower GI</td>
                        <td>Conjugated (Inactive)</td>
                        <td>Excreted in stool</td>
                    </tr>
                    <tr>
                        <td>High Beta-Glucuronidase</td>
                        <td>Lower GI</td>
                        <td>Deconjugated (Active)</td>
                        <td>Reabsorbed into blood</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. Beta-Glucuronidase: The Gatekeeper of Dominance</h2>
        <p>Beta-glucuronidase is not inherently "bad"; it is a necessary enzyme for various metabolic processes. However, <span class="highlight">pathological elevations</span> are a primary driver of estrogen dominance. A 2017 study published in <i>Maturitas</i> demonstrated that women with lower microbial diversity and higher beta-glucuronidase activity had significantly higher levels of circulating estrogens, correlating with increased risks of estrogen-driven cancers.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">60%</div>
                    <div class="stat-label">Estrogen Recycled via High BG</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3.5x</div>
                    <div class="stat-label">Endometriosis Risk Increase</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">25g+</div>
                    <div class="stat-label">Daily Fiber Target</div>
                </div>
            </div>
        </div>

        <p>When beta-glucuronidase levels are high, the body effectively "overdoses" on its own recycled estrogen. This is particularly problematic in conditions like <span class="highlight">PCOS, Endometriosis, and Uterine Fibroids</span>, where the hormonal "load" is already skewed. As a coach, identifying high beta-glucuronidase (often via a GI-Map or similar stool test) is a non-negotiable step in the "B" (Baseline) phase.</p>

        <h2 id="section4">4. Dysbiosis & Estrogen Dominance: The Clinical Connection</h2>
        <p>What causes a "lazy" or "overactive" estrobolome? The primary culprit is <span class="highlight">dysbiosis</span>â€”an imbalance between beneficial and pathogenic microbes. Specific bacterial species, including <i>Bacteroides fragilis</i> and various <i>Clostridia</i>, are known high-producers of beta-glucuronidase.</p>

        <p>Furthermore, the <span class="highlight">Firmicutes to Bacteroidetes (F/B) ratio</span> plays a role. A high F/B ratio is often associated with obesity and metabolic syndrome, but it also correlates with altered estrogen metabolism. Because estrogen itself can influence the gut environment, this creates a "vicious cycle": high estrogen promotes a gut environment that produces more beta-glucuronidase, which in turn leads to even higher estrogen.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study 1: The Recycled Estrogen Trap</p>
                    <p class="subtitle">Chronic Bloating & Severe PMS</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 34</h4>
                        <p>Symptoms: Grade 4 PMS, heavy clotting, cystic acne, chronic constipation.</p>
                    </div>
                </div>
                <p><strong>Baseline Assessment (B):</strong> Sarah had been "eating clean" but suffered from constipation (1 BM every 2-3 days). Serum labs showed high Estradiol (340 pg/mL in mid-luteal phase). A stool analysis revealed elevated Beta-glucuronidase (2,400 U/mL; Range &lt;1,100).</p>
                <p><strong>Intervention (O):</strong> Instead of using hormone-blocking herbs immediately, we focused on the estrobolome. We introduced 500mg of <span class="highlight">Calcium-D-Glucarate</span> twice daily to inhibit the enzyme and increased soluble fiber to 35g/day to ensure daily elimination.</p>
                <p><strong>Outcome:</strong> Within two cycles, Sarah's heavy clotting reduced by 50%, and her cystic acne cleared. By addressing the "exit" (Phase 3), we resolved the "load" at the source.</p>
            </div>
        </div>

        <h2 id="section5">5. Interventions to Modulate the Estrobolome</h2>
        <p>As a Hormone Health Coach, your toolkit for the estrobolome focuses on reducing enzyme activity and ensuring efficient transit time. If the stool sits in the colon for 48-72 hours, there is more time for deconjugation and reabsorption to occur.</p>

        <div class="key-terms-box">
            <p class="box-label">The Estrobolome Toolkit</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Calcium-D-Glucarate</p>
                    <p class="definition">A supplement that directly inhibits beta-glucuronidase, preventing the "unzipping" of estrogen in the gut.</p>
                </div>
                <div class="term-item">
                    <p class="term">Sulforaphane / DIM</p>
                    <p class="definition">Compounds from cruciferous vegetables that support Phase 2 liver pathways, ensuring estrogen is properly conjugated before it hits the gut.</p>
                </div>
                <div class="term-item">
                    <p class="term">Prebiotic Fiber</p>
                    <p class="definition">Inulin and PHGG help lower colonic pH. An acidic environment inhibits the activity of beta-glucuronidase producing bacteria.</p>
                </div>
                <div class="term-item">
                    <p class="term">Probiotic Strains</p>
                    <p class="definition"><i>Lactobacillus acidophilus</i> and <i>Bifidobacterium lactis</i> have been shown to modulate enzyme activity and improve transit time.</p>
                </div>
            </div>
        </div>

        <h2 id="section6">6. Implementation: The B.L.O.O.M. Methodâ„¢ Approach</h2>
        <p>When working with a client exhibiting signs of estrogen dominance (tender breasts, heavy periods, mood swings), do not jump straight to progesterone support. Follow the <span class="highlight">B.L.O.O.M. Methodâ„¢</span> sequence:</p>
        
        <ol class="content-list">
            <li><strong>Baseline Assessment (B):</strong> Evaluate bowel frequency and stool consistency. Order a stool test if beta-glucuronidase is suspected.</li>
            <li><strong>Listen to Your Body (L):</strong> Have the client track the relationship between their bloating and their menstrual phase. Estrogen slows motility; the "period poop" phenomenon is often a result of shifting prostaglandins and estrogen levels.</li>
            <li><strong>Optimize Hormones (O):</strong> Use Calcium-D-Glucarate (500-1,000mg/day) during the luteal phase to assist the estrobolome.</li>
            <li><strong>Overcome Symptoms (O):</strong> Address the immediate discomfort of bloating through bitter herbs and digestive enzymes while the microbiome shifts.</li>
            <li><strong>Maintain (M):</strong> Transition to a high-fiber, diverse plant-based diet to keep the estrobolome resilient for the long term.</li>
        </ol>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">How does an elevated level of Beta-glucuronidase contribute to Estrogen Dominance?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">It acts as an enzyme that deconjugates (unpacks) estrogen that was previously neutralized by the liver. This allows the now active estrogen to be reabsorbed through the gut wall into the bloodstream, increasing the total systemic hormonal load.</div>
            </div>
            <div class="question-item">
                <p class="question-text">Which specific supplement is considered a direct inhibitor of the beta-glucuronidase enzyme?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Calcium-D-Glucarate is the primary nutraceutical used to inhibit beta-glucuronidase activity in the intestines.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The estrobolome is the gut's "hormone control center," regulating the excretion vs. reabsorption of estrogen.</li>
                <li>Beta-glucuronidase is the "gatekeeper" enzyme; high levels lead to estrogen recycling and dominance.</li>
                <li>Gut dysbiosis and slow transit time (constipation) are the primary drivers of an impaired estrobolome.</li>
                <li>Effective intervention requires a combination of enzyme inhibition (Calcium-D-Glucarate) and lifestyle support (Fiber/Probiotics).</li>
                <li>Always assess gut function in the <strong>Baseline (B)</strong> phase before intervening with direct hormonal precursors.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Plottel, C. S., & Blaser, M. J. (2011). "Microbiome and malignancy." <i>Cell Host & Microbe</i>.</li>
                <li>Baker, J. M. et al. (2017). "Estrogenâ€“gut microbiome axis: Physiological and clinical implications." <i>Maturitas</i>.</li>
                <li>Kwa, M. et al. (2016). "The Intestinal Microbiome and Estrogen Receptorâ€“Positive Female Breast Cancer." <i>Journal of the National Cancer Institute</i>.</li>
                <li>Siddiqui, R. et al. (2022). "The Gut Microbiome and Female Health: A Review." <i>Microorganisms</i>.</li>
                <li>Parida, S., & Sharma, D. (2019). "The Microbiomeâ€“Estrogen Connection and Breast Cancer Risk." <i>Cells</i>.</li>
                <li>Ervin, S. M. et al. (2019). "Gut microbial Î²-glucuronidases: a golden era of discovery." <i>Current Opinion in Chemical Biology</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Hormone Health Coach Certification | Advanced Module 15</p>
        </footer>
    </div>
</body>

</html>